Bongolan, Mychill O.
HRN: 21-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2022
07/20/2022
IV
4.5g
Q8
G2P1 (1011); Complete Abortion; UTI
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes